CClinicalTrials.gg
Active, not recruitingNCT06495801Updated May 2, 2025

Effectiveness of a Mobile Application in Improving Employees' Social Well-being.

An interventional study of Frendie PRO mobile application in Loneliness, Social Isolation and Social Support, sponsored by University of Eastern Finland. Active, not recruiting at 1 site in Finland. Open to participants aged 16 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-02.

Sponsored by University of Eastern Finland · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 4 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
1,012
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

The goal of this cluster randomized controlled trial is to learn if using Frendie PRO mobile application at workplaces improves social well-being in employees. The main questions it aims to answer are:

Does using Frendie PRO mobile application at work for 6 months reduce loneliness in employees? Does using Fendie PRO mobile application at work for 6 months reduce social isolation in employees?

Researchers will compare employees from workplaces that use the Frendie PRO mobile application to employees from workplaces that do not use the mobile application to see if there are differences in their levels of social well-being (loneliness, social isolation, perceived social support, depressive symptoms).

Participants will be given access to the Frendie PRO mobile application and encouraged to use it by employers.

Read the detailed description

Participants will be recruited from workplaces that use the Frendie PRO mobile application. After collecting baseline data, each workplace will be randomly assigned to treatment or control conditions. The unit of randomization is a workplace (or a team or department in bigger organizations).

The intervention group will be encouraged to download and start using the Frendie PRO mobile application. The control group will be informed of the date when they will have access to it (six months after the baseline).

Both groups are asked to participate in two follow-ups - a 3-month follow-up and a 6-month follow-up.

02

Conditions studied

  • Loneliness
  • Social Isolation
  • Social Support
  • Depressive Symptoms

Browse trials for

Keywords

  • loneliness
  • work well-being
  • social well-being
03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's planned enrollment of 1,012 is above the median of 84 across 6,720 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

University of Eastern Finland is the lead sponsor of 51 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • All employees working at the company/team/department participating in the study and starting to use the Frendie PRO mobile application within the study period.
  • Ability to fill the questionnaires online in Finnish

Exclusion criteria

Exclusion Criteria:

  • incapable of using questionnaire online
  • does not know Finnish well enough to answer the questions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,012 participants (estimated)

Study arms

  • Experimental
    Intervention

    Behavioral: Frendie PRO mobile application

  • No intervention
    Wait-list controls

    The group will have access to the mobile application after the six-month follow-up period.

Interventions

  • BehavioralFrendie PRO mobile application

    Frendie PRO mobile application offers employees an environment to manage their social relationships, organize leisure activities, and discuss personal or work-related matters.

06

What researchers measure

Primary outcomes

  1. Loneliness

    University of California, Los Angeles (UCLA) Loneliness Scale

    Time frame: Will be measured three times: baseline, 3-month follow-up and 6-month follow-up

  2. Social Isolation

    The Social Isolation scale was modified from an index used by Christiansen et al. (2021). Christiansen and colleagues, in turn, created it inspired by the detailed Social Network Index created by Berkman and Syme (1979). Communication frequency with the following groups is measured: * family members who live elsewhere * friends * colleagues or fellow students at the workplace/school and outside of the workplace/school * neighbors and local community * people from social clubs, hobby groups, and religious organisations at and outside the meetings.

    Time frame: Will be measured three times: baseline, 3-month follow-up and 6-month follow-up

Secondary outcomes

  1. Social support

    Oslo Social Support Scale

    Time frame: Will be measured three times: baseline, 3-month follow-up and 6-month follow-up

  2. Depressive symptoms

    Patient Health Questionnaire-9 (PHQ9)

    Time frame: Will be measured three times: baseline, 3-month follow-up and 6-month follow-up

  3. Workplace loneliness

    Specific scale regarding loneliness experienced at workplaces. Includes 5 items that are modified from the UCLA loneliness scale. It was validated in Finnish adult population. Please see Kemppinen and Tanskanen (2023) for full description: Kemppinen, S., Tanskanen, J., 2023. Suomenkielisen työyksinäisyysmittarin validointi etä- ja hybridityöläisillä (Eng title: Validation of Finnish loneliness at work scale with remote and hybrid worker sample). Psykologia 58, 198-219.

    Time frame: Will be measured three times: baseline, 3-month follow-up and 6-month follow-up

Other outcomes

  1. Activity and behavior on the application

    Each individual user's activity on the mobile application will be measured. The data will be used for additional analyses.

    Time frame: 6 months

07

Study locations

1 site
  • University of Eastern Finland
    Kuopio, North Savonia 70110, Finland
08

References and documents

Individual participant data

Plan to share: Yes — After 10 years, anonymized data will be offered to the Finnish Social Science Data Archive. If the data will not be accepted there, it will be destroyed.

Supporting information: Study protocol, Icf, Csr

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06495801
Lead sponsor
University of Eastern Finland
Collaborators
Finnish Work Environment Fund
Responsible party
Siiri-Liisi Kraav (Post-doctoral researcher, University of Eastern Finland) — Principal investigator
First posted
Jul 11, 2024
Start date
Sep 20, 2024
Primary completion
May 20, 2025 (estimated)
Completion
Aug 1, 2025 (estimated)
Last update
May 2, 2025

Study contacts

Siiri-Liisi Kraav, PhD
principal investigator · University of Eastern Finland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion